Posts Tagged ‘healthcare’

Bionow Annual Awards 2013 Winners

Written by UMIP on . Posted in News

Bionow are delighted to announce the winners of the 2013 Bionow Annual Awards. The Winners were announced at the Prestigious Bionow Annual Awards Dinner on the evening of Thursday 28th November at the Mere Golf Resort & Spa, Cheshire. The Awards Dinner showcases the very best of this world class sector and this year was attended by over 330 executives from across the biomedical industry. The event was hosted by Dr John Stageman OBE, Chair of Bionow and Dr Geoff Davison, CEO of Bionow.

  • Start-Up Company of the Year – Sponsored By Baker Tilly Winner: Proveca
  • Promising Technologist of the Year – Sponsored by Novartis Vaccines Winner: Ralph Kirk, Redx Pharma
  • Healthcare Project of the Year – Sponsored by TRUSTECH Winner: PROMs 2.0, Central Manchester Foundation Trust
  • Best Product or Service of the Year – Sponsored by UL EduNeering Winner: ZedScan I, Zilico
  • Biomedical Project of the Year – Sponsored by Waters Corporation Winner: Enhanced Biofilm dispersion, Newcastle University
  • Investment Deal of the Year – Sponsored by DWF LLP Winner: Imagen Biotech
  • Service Company of the Year – Sponsored by Pinsent Masons LLP Winner: Cyprotex
  • Innovative Ageing of the Year Award – Sponsored by MIMIT / Edwards Healthcare Winner: ELAROS, Medical Devices Technology
  • International Company of the Year – Sponsored by AstraZeneca Winner: Redx Pharma

www.bionow.co.uk

 

UMIP - REPUTATION AND VALUE THROUGH INTELLECTUAL PROPERTY®

Privacy Policy / Terms and Conditions / © Copyright 2015 The University of Manchester Intellectual Property / Created by HTP Digital Marketing Agency

The University of Manchester Intellectual Property ("UMIP") acts solely as agent for the University in relation to any matter relating to intellectual property ("IP") and know how created at the University. This is whether such IP is created by employees, students or others. UMIP does not represent anyone else in such matters. If anyone else requires advice in relation to such IP then they must take their own independent legal advice.